Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met
1999 · Journal of Biological Chemistry · 226 citations
https://doi.org/10.1074/jbc.274.10.6499
S
Steven T. Pals
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
346
Papers
26.7K
Citations
83
h-index
222
i10-index
Steven T. Pals is an academic researcher from Cancer Targeted Technology (United States). The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Proteoglycans and glycosaminoglycans research & T-cell and B-cell Immunology. The author has an h-index of 83, co-authored 295 publications.
ORCID: 0000-0002-1419-0939Papers by this author
worksHigh prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
2013 · Blood Cancer Journal · 201 citations
https://doi.org/10.1038/bcj.2013.28
Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway.
1990 · The Journal of Immunology · 183 citations
https://doi.org/10.4049/jimmunol.145.11.3589
Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
2019 · Leukemia · 180 citations
https://doi.org/10.1038/s41375-019-0404-1
Evidence that leukocyte function-associated antigen-1 is involved in recirculation and homing of human lymphocytes via high endothelial venules.
1988 · The Journal of Immunology · 115 citations
https://doi.org/10.4049/jimmunol.140.6.1851
Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma
2009 · Blood · 105 citations
https://doi.org/10.1182/blood-2009-02-204396
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat